{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "MAP2K2",
                "DNA Alteration": "c.383C>T",
                "GeneMutation": "p.P128L Frameshift-LOF",
                "VariantAlleleFraction": "12.58%"
            },
            {
                "Gene": "HRAS",
                "DNA Alteration": "c.35G>T",
                "GeneMutation": "p.G12V Stopgain-LOF",
                "VariantAlleleFraction": "11.95%"
            },
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": " p.W266* Frameshift-GOF",
                "VariantAlleleFraction": "6.95%"
            },
            {
                "Gene": "NOTCH1",
                "DNA Alteration": "c.7507C>T",
                "GeneMutation": "p.S2467Gfs*11 Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.65%"
            },
            {
                "Gene": "STAG2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R1012X Frameshift-LOF",
                "VariantAlleleFraction": "4.25%"
            },
            {
                "Gene": "MUTYH",
                "DNA Alteration": "c.1014G>C",
                "GeneMutation": "p.Q338H Frameshift-LOF",
                "VariantAlleleFraction": "9.5%"
            },
            {
                "Gene": "MPL",
                "DNA Alteration": "c.1543_1544delinsAA",
                "GeneMutation": "p.W515L Nonsense-GOF",
                "VariantAlleleFraction": "4.12%"
            },
            {
                "Gene": "CHEK2",
                "DNA Alteration": "c.470T>C",
                "GeneMutation": "p.S428F Nonsense-LOF",
                "VariantAlleleFraction": "6.82%"
            }
        ],
        "Germline": [
            {
                "Gene": "SDHD",
                "DNA Alteration": "c.34G>A",
                "GeneMutation": "p.G12S Spliceregionvariant-LOF",
                "Condition": "local"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.380G>C",
                "GeneMutation": "p.E318D Nonsense-GOF",
                "Condition": "night"
            }
        ]
    }
}